Apolipoprotein E genotype and lifetime cognitive decline.

Apolipoprotein E genotype and lifetime cognitive decline. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Apolipoprotein E genotype and lifetime cognitive decline. Abstract Text:

Nicholas A Kozauer,Michelle M Mielke,Gary Kwun Chuen Chan,George W Rebok,Constantine G Lyketsos,

ABSTRACTObjective: The relationship of apolipoprotein E (APOE) genotype to lifetime cognitive decline was examined over 22 years in a large community-based population study.Method: The sample for the present study was derived from follow-up of a probability sample of the adult household residents of East Baltimore. From the Baltimore cohort of the Epidemiologic Catchment Area Study, genotype data were collected on 818 participants at the study's fourth wave between 2003 and 2004. Participants were administered the Mini-mental State Examination (MMSE) at all four study waves. Three tests of verbal learning - immediate recall, delayed recall, and word recognition - were completed at waves 3 and 4. The 659 participants for whom genetic data were available had also completed cognitive testing at all time points. Test scores and changes in these scores were examined by APOE genotype group (x/x or 4/x) in younger and older subcohorts defined by age at wave 4 (< or >/= age 65).Results: Cross-sectional wave 4 scores on all four cognitive tasks were lower in APOEepsilon4 carriers when compared to non-carriers. In longitudinal univariate models epsilon4 carriers in the younger cohort demonstrated a greater annual rate of decline on a delayed recall task and MMSE. After adjusting for covariates only the decline in the delayed recall task was significant.Conclusion: We report an association between APOE genotype and decline in delayed recall and possibly MMSE over this extended time period limited to younger individuals. The lack of an association between APOE and decline in older individuals is likely to be the result of survival bias. Although a clear association exists between APOE genotype and cognitive decline or dementia in late life, these findings suggest that over the lifespan the relationship between APOE and cognitive decline is more complicated.

Apolipoprotein E genotype and lifetime cognitive decline. Publishing Authors By Initials

NA Kozauer,MM Mielke,GK Chuen Chan,GW Rebok,CG Lyketsos,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Apolipoprotein E genotype and lifetime cognitive decline. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: International psychogeriatrics / IPA

VOLUME: 20

Page Numbers: 109-23

Journal Abbreviation:

ISSN: 1041-6102

DAY: 22

MONTH: 08

YEAR: 2007

Apolipoprotein E genotype and lifetime cognitive decline. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9007918

Apolipoprotein E genotype and lifetime cognitive decline. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Apolipoprotein E genotype and lifetime cognitive decline. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Apolipoprotein E genotype and lifetime cognitive decline.

AFFILIATION: Division of Geriatric and Neuropsychiatry, Johns Hopkins School of Medicine, Baltimore, U.S.A.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int Psychogeriatr

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Apolipoprotein E genotype and lifetime cognitive decline Related Publications

• A clinical approach to mild cognitive impairment.
• A comparison of small and large assisted living facilities for the diagnosis and care of dementia: the Maryland Assisted Living Study.
• Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention.
• Apolipoprotein E genotype and lifetime cognitive decline.
• Clozapine for treatment-resistant agitation in dementia.
• Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis.
• Depression in assisted living is common and related to physical burden.
• Differentiating Alzheimer's disease and frontotemporal dementia: receiver operator characteristic curve analysis of four rating scales.
• Epidemiology of apathy in older adults: the Cache County Study.
• Examining a bidirectional association between depressive symptoms and diabetes.
• Influence of social network characteristics on cognition and functional status with aging.
• Mild cognitive impairment: searching for the prodrome of Alzheimer's disease.
• Prevalence of psychiatric disorders in Athens. A community study.
• Race and restless legs syndrome symptoms in an adult community sample in east Baltimore.
• Rates of depression in individuals with pathologic but not clinical Alzheimer disease are lower than those in individuals without the disease: findings from the Baltimore Longitudinal Study on Aging (BLSA).
• Restless Legs Syndrome is Associated with DSM-IV Major Depressive Disorder and Panic Disorder in the Community.
• Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study.
• The association between activity participation and time to discharge in the assisted living setting.
• Vascular factors predict rate of progression in Alzheimer disease.